STU

Ascendis Pharma A/S (A71)

Ascendis Pharma A/S (A71) is listed on STU. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Key metrics for A71

P/E ratio
18.00

Ascendis Pharma A/S (A71) — FAQ

What is A71's P/E ratio?

The price-to-earnings (P/E) ratio for Ascendis Pharma A/S (A71) is 18.00 (data as of 2026-05-23).

Does Ascendis Pharma A/S pay a dividend?

Dividend yield is not available in the current snapshot for Ascendis Pharma A/S (A71). Check the MyAverix Finance app for the latest dividend data.

What exchange is A71 listed on?

A71 is listed on STU.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

App Store Google Play